EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

Evaluation of platelet-rich fibrin matrix combined with PGE-1 injection on erectile function in patients with refractory response to PDE5-I: a randomized placebo-controlled study

Adham Zaazaa, Mohamed Abbas Eid, Sameh Fayek GamalEl Din, Ashraf Zeidan, Ahmed AbdEl Hakeem, Mohamed Abdel Fattah Farag, Ahmed Fawzy, Amr Kaddah

International Urology and Nephrology · 2024

DOI: 10.1007/s11255-024-04139-w ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift International Urology and Nephrology, 2024. Verfasst von Adham Zaazaa und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Andrology, Sexology and STDs Kasr Al-Ainy, Faculty of Medicine, Cairo University, Al-Saray Street, El Manial, Cairo, 11956, Egypt. Hauptthemen laut MEDLINE: Alprostadil, Erectile Dysfunction, Phosphodiesterase 5 Inhibitors, Penile Erection. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 35 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: We studied the effect of a platelet-rich fibrin matrix (PRFM) combined with prostaglandin E-1 (PGE-1) injection on erectile function in patients refractory to response for phosphodiesterase type 5 inhibitors (PDE5-Is). METHODS: This randomized, double-blind, placebo-controlled study included 80 patients. The patients were randomly assigned to four groups and blinded together with the administrating physicians to the nature of the intracorporeal injection (ICI) therapies. Group (1) received saline, group (2) received platelet-rich fibrin matrix (PRFM), group (3) received prostaglandin E-1 (PGE-1), and group (4) received a combination of PRFM + PGE-1. The patients received ICI therapy weekly for 8 consecutive weeks. Clinical information and follow-up data were obtained at 1, 2, 3, and 6 months. RESULTS: A significant increase occurred in the validated Arabic version of the International Index of Erectile Function (ArIIEF-5) score in group (4) compared to the other three groups (p value = 0.037). There was a significant difference in erection hardness scale (EHS) scores among all groups after receiving the different treatments (p = 0.004). A significant increase was seen in the ArIIEF-5 score in groups 4 and 3 compared to that in groups 1 and 2 (p < 0.001). There was also a significant increase in the arterial dilatation % in groups 4 and 3 compared to that in groups 1 and 2 (p = 0.019). CONCLUSION: The combination of PRFM plus PGE-1 had shown significant improvement in the ArIIEF-5 score, yet the patients still had mild to moderate ED.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AlprostadilErectile DysfunctionPhosphodiesterase 5 InhibitorsPenile ErectionPlatelet-Rich FibrinHumansMaleDouble-Blind MethodMiddle AgedAdultInjectionsVasodilator AgentsAged

Stichwörter der Autor:innen

Erectile dysfunctionIntracorporeal injectionPGE-1Platelet-rich fibrin matrixRefractory response to PDE5-IVasculogenic erectile dysfunction

Substanzen

AlprostadilPhosphodiesterase 5 InhibitorsVasodilator Agents

Autor:innen und Institutionen

  • Department of Andrology, Sexology and STDs Kasr Al-Ainy, Faculty of Medicine, Cairo University, Al-Saray Street, El Manial, Cairo, 11956, Egypt.
  • Department of Andrology, Sexology and STDs Kasr Al-Ainy, Faculty of Medicine, Cairo University, Al-Saray Street, El Manial, Cairo, 11956, Egypt. samehfayek@kasralainy.edu.eg.
  • Egypt Ministry of Health and Population, Cairo, Egypt.

Zitieren

APA

Zaazaa, A., Eid, M. A., GamalEl Din, S. F., Zeidan, A., Hakeem, A. A., Farag, M. A. F., Fawzy, A., & Kaddah, A. (2024). Evaluation of platelet-rich fibrin matrix combined with PGE-1 injection on erectile function in patients with refractory response to PDE5-I: a randomized placebo-controlled study. International Urology and Nephrology. https://doi.org/10.1007/s11255-024-04139-w

Vancouver

Zaazaa A, Eid MA, GamalEl Din SF, Zeidan A, Hakeem AA, Farag MAF, et al. Evaluation of platelet-rich fibrin matrix combined with PGE-1 injection on erectile function in patients with refractory response to PDE5-I: a randomized placebo-controlled study. International Urology and Nephrology. 2024. doi:10.1007/s11255-024-04139-w

BibTeX
@article{Zaazaa2024,
  author = {Zaazaa, Adham and Eid, Mohamed Abbas and GamalEl Din, Sameh Fayek and Zeidan, Ashraf and Hakeem, Ahmed AbdEl and Farag, Mohamed Abdel Fattah and Fawzy, Ahmed and Kaddah, Amr},
  title = {Evaluation of platelet-rich fibrin matrix combined with PGE-1 injection on erectile function in patients with refractory response to PDE5-I: a randomized placebo-controlled study},
  journal = {International Urology and Nephrology},
  year = {2024},
  doi = {10.1007/s11255-024-04139-w}
}
Kostenlos starten →